中重度银屑病有效治疗后述情障碍的可逆性:EPIDEPSO研究纵向数据
EPIDEPSO是一项为期1年的多中心观察性研究,纳入病程≤10年且适合系统治疗的银屑病患者,用多伦多述情障碍量表(TAS-20)在基线、6个月和1年评估。随访队列述情障碍患病率从基线26.7%降至6个月21.2%、1年18.8%,基线述情障碍者中53.8%发生逆转,且逆转与皮损高度控制、生活质量及焦虑抑郁改善相关。
要点
- 随访队列述情障碍患病率从基线26.7%降至6个月21.2%、1年18.8%。
- 基线述情障碍患者中53.8%(n=77)发生逆转。
- 达PASI改善≥75%或≥90%高度疾病控制者逆转率更高。
核心结论
- 作者认为,银屑病有效治疗后述情障碍及相关高疾病负担可能可逆。
- 作者认为,主动识别无法识别和表达情绪的患者很重要。
研究设计与样本
- EPIDEPSO(NCT01964443)是一项为期1年的多中心观察性研究。
- 研究对象为病程≤10年且适合系统治疗的银屑病患者。
- 用多伦多述情障碍量表(TAS-20)在基线、6个月和1年评估述情障碍。
主要发现
- 随访队列述情障碍患病率从基线26.7%降至6个月21.2%、1年18.8%,差异有统计学意义。
- 基线述情障碍患者中53.8%(n=77)发生逆转。
- 达PASI改善≥75%或≥90%高度疾病控制者,述情障碍逆转率更高。
- 述情障碍逆转与生活质量、焦虑和抑郁的大幅改善相关。
- 基线述情障碍患者中高度流行的危险饮酒在1年时减少近三倍。
关键数值与推荐
- 述情障碍评估采用多伦多述情障碍量表(TAS-20)。
- 高度疾病控制定义为PASI改善≥75%或≥90%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alexithymia refers to difficulty in identifying and expressing emotions. Alexithymia is associated with high burden of disease in patients with psoriasis. OBJECTIVES: To investigate whether alexithymia was reversible in patients with psoriasis following real-life therapeutic intervention. METHODS: The Epidemiological Study in Patients with Recently Diagnosed Psoriasis (EPIDEPSO; NCT01964443) was a 1-year multicentre observational study investigating the prevalence of alexithymia and other psychosocial comorbidities in patients with psoriasis with ≤ 10 years' disease duration and eligible for systemic treatment. Alexithymia was assessed using the Toronto Alexithymia Scale (TAS-20) at baseline, 6 months and 1 year. RESULTS: There was a statistically significant decrease in the prevalence of alexithymia in the follow-up cohort, from 26·7% at baseline to 21·2% at 6 months and 18·8% at 1 year. More than half of the patients (n = 77, 53·8%) who were alexithymic at baseline experienced reversion of their alexithymia. Reversion of alexithymia was higher in patients who reached a high level of disease control, defined as ≥ 75% or ≥ 90% improvement in Psoriasis Area and Severity Index. Reversion of alexithymia was associated with dramatic improvement in quality of life, anxiety and depression. Moreover, hazardous alcohol use, highly prevalent in patients with alexithymia, was reduced almost threefold at 1 year. CONCLUSIONS: Alexithymia and associated high disease burden may be reversible in patients with effective treatment of psoriasis. Proactive recognition of patients who are unable to identify and express their feelings is important.
引用
- Sampogna F, Puig L, Spuls P, et al. Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO. Br J Dermatol. 2018. PMID: 30269346. doi:10.1111/bjd.17259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。